Is cannabis consumption favorable to urological cancers? A study of 150,000 patients sheds new light
A new study published by Cancer Medicine explored the association between cannabis use and the risk of urological cancers. Researchers analyzed the cannabis use of 151,945 people with information on cannabis use in the UK Biobank from 2006 to 2010.
Regarding the study method, "Crude and age-standardized incidence rates of different urological cancers were assessed across the entire cohort and subgroups. Cox regression was performed for survival analysis,” said the study by researchers from China, the United Kingdom, and France.”
Another association between previous cannabis use and renal cell carcinoma, as well as bladder cancer, was observed in women, but not in men. The study also found no significant association between cannabis use and testicular cancer.
Conclusion: "Previous cannabis use was associated with a lower risk of bladder cancer, renal cell carcinoma, and prostate cancer," the researchers said. "The inverse association between cannabis and renal cell carcinoma and bladder cancer was found only in women but not in men."
Prostate cancer is the most common form of cancer in men in the UK, with around 52,300 new cases each year.
The study showed similar results to previous studies that recognized an association between cannabis use and a lower risk of developing cancers such as bladder, neck, and liver. According to a study published in the journal Cureus, in a trial that included participants enrolled in the New York State Medical Cannabis Registry, patients with advanced cancer respond favorably to cannabis medical.
"The objectives of this study were to examine the characteristics of patients who received medical marijuana in our outpatient palliative care program and to determine barriers to access and the use of medical marijuana in this population," the study reads. Photo: Courtesy of Braňo on Unsplash
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
A new study published by Cancer Medicine explored the association between cannabis use and the risk of urological cancers. Researchers analyzed the cannabis use of 151,945 people with information on cannabis use in the UK Biobank from 2006 to 2010.
Regarding the study method, "Crude and age-standardized incidence rates of different urological cancers were assessed across the entire cohort and subgroups. Cox regression was performed for survival analysis,” said the study by researchers from China, the United Kingdom, and France.”
Another association between previous cannabis use and renal cell carcinoma, as well as bladder cancer, was observed in women, but not in men. The study also found no significant association between cannabis use and testicular cancer.
Conclusion: "Previous cannabis use was associated with a lower risk of bladder cancer, renal cell carcinoma, and prostate cancer," the researchers said. "The inverse association between cannabis and renal cell carcinoma and bladder cancer was found only in women but not in men."
Prostate cancer is the most common form of cancer in men in the UK, with around 52,300 new cases each year.
The study showed similar results to previous studies that recognized an association between cannabis use and a lower risk of developing cancers such as bladder, neck, and liver. According to a study published in the journal Cureus, in a trial that included participants enrolled in the New York State Medical Cannabis Registry, patients with advanced cancer respond favorably to cannabis medical.
"The objectives of this study were to examine the characteristics of patients who received medical marijuana in our outpatient palliative care program and to determine barriers to access and the use of medical marijuana in this population," the study reads. Photo: Courtesy of Braňo on Unsplash
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
What's Your Reaction?
